The effect of topically applied salicylic compounds on serotonin-induced scratching behaviour in hairless rats.
There is a strong need for antipruritic substances for treating itch in clinical dermatology. In one recent human study, topically applied acetylsalicylic acid has been described to rapidly decrease histamine-induced itch. We have established a model for periferally elicited pruritus by injecting serotonin into the rostral back area (neck) in rats. Using this model, we aimed to investigate the antipruritic potential of four different salicylic compounds, which all possess different skin penetration characteristics. Eighteen rats were studied for 6 weeks. Prior to serotonin injections (2 mg/ml, 50 micro l), 10 micro l of test substances was applied to a circular area 18 mm in diameter. The four substances were salicylic acid, butyl salicylate, diethylamine salicylate and salicylamide, all solubilized in dimethyl isosorbide to a concentration of 5% w/w. Diethylamine salicylate and salicylamide were previously shown to be slowly absorbed through rat skin in contrast to salicylic acid and butyl salicylate. After serotonin injections, scratching was monitored by video recording for 1.5 h. Compared with the vehicle, a lower number of scratch sequences were seen when diethylamine salicylate (P < 0.001) and salicylamide (P = 0.005) had been applied. The numbers of scratch sequences were lower with diethylamine salicylate and salicylamide than with the vehicle throughout the 1.5-h study period. We conclude that topical application of diethylamine salicylate and salicylamide could suppress serotonin-induced scratching in rats. The antipruritic effect seems to be related to the slow drug release of the two substances. The results may be clinically relevant as serotonin induces itch in humans.
Thomsen
J S
JS
Department of Dermatology, Gentofte Hospital, University of Copenhagen, Niels Andersense Vej 65, DK 2900 Hellerup, Denmark. jeth@gentoftehosp.kbhamt.dk
Simonsen
L
L
Benfeldt
E
E
Jensen
S B
SB
Serup
J
J
D000287:Administration, Topical; D000818:Animals; D000982:Antipruritics / Q000008:administration & dosage*; D005260:Female; D011537:Pruritus / Q000139:chemically induced / Q000188:drug therapy*; D051381:Rats; D011922:Rats, Mutant Strains; D012457:Salicylamides / Q000008:administration & dosage; D012459:Salicylates / Q000008:administration & dosage*; D020156:Salicylic Acid / Q000008:administration & dosage; D012701:Serotonin / Q000494:pharmacology
D000982:Antipruritics; D012457:Salicylamides; D012459:Salicylates; D012701:Serotonin; C026191:diethylamine salicylate; C031060:salicylamide; D020156:Salicylic Acid